Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility
The Journal of Clinical Pharmacology · 2023-12 · 63 (12) · 1371-1376
DOI: 10.1002/jcph.2318 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 10.08.2023. Verfasst von Ting-Ting Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Affiliated Hospital of Jinggangshan University, Ji'an, Jiangxi, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Infertility, Female. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
The purpose of this research was to evaluate the efficacy of 3 ovulation induction therapies for treating infertility in patients with polycystic ovary syndrome (PCOS). In this retrospective study, we compared the success rates of 90 patients who underwent intrauterine insemination, who were randomly assigned to 1 of 3 treatment groups: letrozole (LE) + urinary gonadotropin (human menopausal gonadotropin [HMG]), clomiphene (CC) + HMG, or HMG alone. Using ultrasound scanning, we examined the number of mature follicles, ovulation rate, clinical pregnancy rate, endometrial thickness, and blood flow. When compared to the other 2 groups, the LE + HMG group had significantly higher levels of mature follicles, ovulation rate, clinical pregnancy rate, estradiol, and luteinizing hormone on the day of the human chorionic gonadotropin injection and endometrial receptivity ( P < .05). There was no statistically significant difference between the 3 groups in terms of abortion rate, ectopic pregnancy rate, or adverse reactions. In this research, we found that infertility in patients with PCOS could be effectively treated by combining LE with HMG. This protocol increased ovulation, boosted fertility, and enhanced endometrial receptivity with no increase in adverse reactions. Therefore, it may be a useful clinical approach for inducing ovulation and treating infertility in patients with PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Affiliated Hospital of Jinggangshan University, Ji'an, Jiangxi, China.
- Department of Obstetrics and Gynecology, Affiliated Hospital of Jinggangshan University, Ji'an, Jiangxi, China.
ORCID-Profile: Qing-Mei Peng
Zitieren
APA
Xia, T. T., Zeng, K. F., & Peng, Q. M. (2023). Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility. The Journal of Clinical Pharmacology, 63(12), 1371-1376. https://doi.org/10.1002/jcph.2318
Vancouver
Xia TT, Zeng KF, Peng QM. Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility. The Journal of Clinical Pharmacology. 2023;63(12):1371-1376. doi:10.1002/jcph.2318
BibTeX
@article{Xia2023,
author = {Xia, Ting-Ting and Zeng, Ke-Fei and Peng, Qing-Mei},
title = {Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility},
journal = {The Journal of Clinical Pharmacology},
year = {2023},
volume = {63},
number = {12},
pages = {1371--1376},
doi = {10.1002/jcph.2318}
}
EUVIMED